Skip to content
value.today

Greenlight Biosciences Inc.

🇺🇸 Waltham, Massachusetts, USABiotechnologyFounded 2008
Total raised
$179 M
5 rounds on record
Latest round
$103 M
Jun 2020
First round on record
Jul 2013
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Greenlight Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$103 MNo. 5$50 to $250 million

Greenlight Biosciences Inc.: Raise no. 5, Jun 2020

Investors in this round

19 investors had bought by the notice of Jun 26, 2020: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$103 M of $110 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey Zarur · Executive Officer, Director
  • Charles Cooney · Director
  • Eric O'Brien · Director
  • Ganesh Kishore · Director
  • Jason Dinges · Director
  • Martha Schlicher · Director
  • Matthew Walker · Director
  • Michael Liang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrey Zarur, President & CEO. Source: SEC Form D, newest notice filed Jun 26, 2020. Read the notice at the SEC.

equitySEC
Dec 2018$39 MNo. 4$10 to $50 million

Greenlight Biosciences Inc.: Raise no. 4, Dec 2018

Investors in this round

15 investors had bought by the notice of Dec 19, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $53 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey Zarur · Executive Officer, Director
  • Charles Cooney · Director
  • David Furneaux · Director
  • Eric O'Brien · Director
  • Ganesh Kishore · Director
  • Martha Schlicher · Director
  • Matthew Walker · Director
  • Neil Renninger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrey Zarur, President & CEO. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC
Aug 2017$10 MNo. 3$10 to $50 million

Greenlight Biosciences Inc.: Raise no. 3, Aug 2017

Investors in this round

10 investors had bought by the notice of Sep 14, 2017: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $18 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey Zarur · Executive Officer, Director
  • Marta Ortega-Valle · Executive Officer
  • Charles Cooney · Director
  • David Furneaux · Director
  • Eric O'Brien · Director
  • Ganesh Kishore · Director
  • James Swartz · Director
  • Jonathan Fleming · Director
  • Neil Renninger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrey Zarur, President. Source: SEC Form D, newest notice filed Sep 14, 2017. Read the notice at the SEC.

equitySEC
Jun 2015$20 MNo. 2$10 to $50 million

Greenlight Biosciences Inc.: Raise no. 2, Jun 2015

Investors in this round

7 investors had bought by the notice of Jun 16, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$91,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$675,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey Zarur · Executive Officer, Director
  • Marta L. Ortega-Valle · Executive Officer
  • William L. Blake · Executive Officer
  • Charles L. Cooney · Director
  • David L. Furneaux · Director
  • Ganesh L. Kishore · Director
  • James L. Swartz · Director
  • Jonathan L. Fleming · Director
  • Neil L. Renninger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The Issuer expects to pay approximately $675,000 of the gross proceeds to related persons as compensation, including benefits, over the course of one year.”

Signed by Andrey Zarur, President. Source: SEC Form D, newest notice filed Jun 16, 2015. Read the notice at the SEC.

equitySEC
Jul 2013$8 MNo. 1$2 to $10 million

Greenlight Biosciences Inc.: Raise no. 1, Jul 2013

Investors in this round

3 investors had bought by the notice of Dec 20, 2013: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey Zarur · Executive Officer, Director
  • Charles Cooney · Director
  • David Furneaux · Director
  • Greg Lucier · Director
  • James Swartz · Director
  • Jonathan Fleming · Director
  • Neil Renninger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrey Zarur, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 20, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Greenlight Biosciences Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2020).

    SEC Form D · Jun 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2020

That is all the official record says: Greenlight Biosciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Greenlight Biosciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Greenlight Biosciences Inc.
NameRoleNamed in
Andrey ZarurExecutive officerJun 2020
Marta Ortega-ValleExecutive officerSep 2017
Marta L. Ortega-ValleExecutive officerJun 2015
William L. BlakeExecutive officerJun 2015
Andrey ZarurDirectorJun 2020
Charles CooneyDirectorJun 2020
Eric O'BrienDirectorJun 2020
Ganesh KishoreDirectorJun 2020
Jason DingesDirectorJun 2020
Martha SchlicherDirectorJun 2020
Matthew WalkerDirectorJun 2020
Michael LiangDirectorJun 2020
David FurneauxDirectorDec 2018
Neil RenningerDirectorDec 2018
James SwartzDirectorSep 2017
Jonathan FlemingDirectorSep 2017
Charles L. CooneyDirectorJun 2015
David L. FurneauxDirectorJun 2015
Ganesh L. KishoreDirectorJun 2015
James L. SwartzDirectorJun 2015
Jonathan L. FlemingDirectorJun 2015
Neil L. RenningerDirectorJun 2015
Greg LucierDirectorDec 2013